Cyprotex Contract - Development of a 2D Human Neural Network Formation Assay (To
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new external contract research requirement for the development of a 2D human neural network formation assay within the Human Factors in Pharma (HFP) priority research area focused on developmental neurotoxicity. The solicitation is expected to be released on May 1, 2026, with an estimated award date of September 1, 2026. This contract represents a new requirement that will support FDA's capabilities in assessing potential neurotoxic effects during drug development and regulatory evaluation.
The estimated award value ranges between $25,000 and $250,000, with the work classified under NAICS code 541990 (All Other Professional, Scientific, and Technical Services). Interested contractors should direct inquiries to the FDA's acquisition liaison at hfpacquisitions@fda.hhs.gov. The opportunity does not include any small business set-asides and represents a competitive contracting opportunity open to all qualified vendors.
Forecast text
External contract research support to develop a new assay in the HFP priority research area of developmental neurotoxicity
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast